Evidence 1
Activity
Activity
50% Hemolysis
Toxicity
>500 µg/mL
Hemolytic
Cytotoxic
50% Hemolysis | >500 | µg/mL | target cell: Human erythrocytes
Target
Human erythrocytes
Source & Reference
NA
DBAASP
Periodic antimicrobial peptides. | PATENT US 7091185 B2 | 2006